Article

SARS-CoV-2 variants resist antibody neutralization and broaden host ACE2 usage

2021-03-09

Abstract excerpt

New SARS-CoV-2 variants continue to emerge from the current global pandemic, some of which can replicate faster and with greater transmissibility and pathogenicity. In particular, UK501Y.V1 identified in UK, SA501Y.V2 in South Africa, and BR501Y.V3 in Brazil are raising serious concerns as they spread quickly and contain spike protein mutations that may facilitate escape from current antibody therapies and vaccine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 038e04d5-ec62-58e2-8907-a9bdb504708d
DOI: 10.1101/2021.03.09.434497

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 variants resist antibody neutralization and broaden host ACE2 usageDOI 10.1101/2021.03.09.434497Read

Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.Semantic proximity Read

SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1.Semantic proximity Read

Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasionSemantic proximity Read

Antibody evasion by the P.1 strain of SARS-CoV-2.Semantic proximity Read

Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.Semantic proximity Read

The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunitySemantic proximity Read

Insertion in the N-Terminal Domain of the SARS-CoV-2 Spike Glycoprotein Affects Antibody Recognition and Phenotypic Properties.Semantic proximity Read

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.Semantic proximity Read

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studySemantic proximity Read

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?Semantic proximity Read

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.Semantic proximity Read

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86Semantic proximity Read